Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in ...
Desjardins initiated coverage on EQB Inc (EQB:CN) (OTC: EQGPF), assigning the company's stock a Buy rating along with a price target of C$130.00. The research firm's analysis highlighted EQB's strong ...
Anthos was founded by private equity firm Blackstone's Life Sciences business and by Novartis in 2019 to develop, manufacture ...
Following Trump's lead, organizations including Walmart, Lowe’s and Meta have announced they would scale back their ...
As such, family offices have become an economic force, remaking how the wealth management industry operates and transforming ...
A Win for Trump's Vision of a Fair Workplace** In a significant move applauded by many conservatives, Deloitte, one of the world’s largest consulti ...
Oaktree Capital Management has closed the largest fund in its history, giving the firm a sizable new pool of money to back cash-constrained companies in a range of industries.
His insistence that the Atlanta Public Schools benefit all children laid the groundwork for a conversation about equity that we continue to build on today.
For some, the chaos wrought by Elon Musk and his ironically-named Department of Government Efficiency feels strangely ...
Sidley Austin LLP and Ropes & Gray acted on Access Healthcare's investment from affiliates of New Mountain Capit ...
Private equity firms are looking to round out their investment portfolios as AI continues to transform the advertising industry.
Anthos was founded by private equity firm Blackstone's Life Sciences business and by Novartis in 2019 to develop, manufacture ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results